LTFS
XBIT icon

Ladenburg Thalmann Financial Services’s XBiotech XBIT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-600
Closed -$7K – 4823
2015
Q4 		$7K Hold
600
– – ﹤0.01% 3904
2015
Q3 		$9K Hold
600
– – ﹤0.01% 3614
2015
Q2 		$11K Buy
+600
New +$12.4K ﹤0.01% 3639

Other funds holding XBIT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ladenburg Thalmann Financial Services's XBIT Position: Q1 2016 in Review

Ladenburg Thalmann Financial Services sold out of XBiotech (XBIT) in Q1 2016, closing a stake of 600 shares — an estimated $7K sold.

Ladenburg Thalmann Financial Services first reported a position in XBIT in Q2 2015 and held it in 3 quarters. The position peaked at $11K in Q2 2015. 32 funds tracked by Wall St. Rank hold XBIT as of Q1 2016.

  • Ladenburg Thalmann Financial Services reported no remaining XBiotech position as of Q1 2016 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 600 XBiotech shares in Q1 2016, an estimated $7K.
  • Ladenburg Thalmann Financial Services first reported a position in XBiotech in Q2 2015 and held it in 3 quarters.
  • Ladenburg Thalmann Financial Services's XBiotech position peaked at $11K in Q2 2015.
  • 32 funds tracked by Wall St. Rank held XBiotech as of Q1 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2016, filed 16 May 2016.